tradingkey.logo
tradingkey.logo
Search

Sonoma Pharmaceuticals Inc

SNOA
Add to Watchlist
1.100USD
-0.030-2.65%
Close 07-31 16:00ETQuotes delayed by 15 min
1.98MMarket Cap
LossP/E TTM

More Details of Sonoma Pharmaceuticals Inc Company

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc Info

Ticker SymbolSNOA
Company nameSonoma Pharmaceuticals Inc
IPO dateJan 26, 2007
CEOTrombly (Amy)
Number of employees168
Security typeOrdinary Share
Fiscal year-endJan 26
Address5445 Conestoga Court, Suite 150
CityBOULDER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80301
Phone18007599305
Websitehttps://sonomapharma.com/
Ticker SymbolSNOA
IPO dateJan 26, 2007
CEOTrombly (Amy)

Company Executives of Sonoma Pharmaceuticals Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--

FAQs

Who are the top five shareholders of Sonoma Pharmaceuticals Inc?

The top five shareholders of Sonoma Pharmaceuticals Inc are: Dr. Jay E. Birnbaum, Ph.D.

How many institutions hold shares of Sonoma Pharmaceuticals Inc (SNOA)?

As of 2026Q1, 40 institutions hold shares of Sonoma Pharmaceuticals Inc, with a combined market value of approximately 127.80K, accounting for 3.68% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -34692.00.

What is the biggest source of revenue for Sonoma Pharmaceuticals Inc?

In 2026Q1, the Human Care business generated the highest revenue for Sonoma Pharmaceuticals Inc, amounting to 3.86M and accounting for 88.83% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.